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Fundamental Aspects of
DoseResponse Relationships and
Their Extrapolation for Noncarcinogenic
Effects of Metals
by Gunnar F. Nordberg* and Per Strangertt
Fundamental differences in dose-response relationships between "stochastic" and "nonstochastic"
effects ofchemicals are identified and discussed. The difficulties in extrapolating into the low-dose region
ofdose-response curves are pointed out. In some instances ofnonstochastic effects, observations concern-
ing interindividual variability in biological half-time and threshold body burden for symptoms may be
used for such extrapolation. An example based on data from the literature concerning effects of methyl-
mercury on the nervous system is given. The confidence intervals of the extrapolated risk-values are
computed and discussed in relation to assumptions concerning the mathematical model to be used in the
extrapolation process.
Introduction
There are considerable differences in the type of
biological disturbance lying behind various effects
resulting from exposure to chemical toxicants. It is
therefore not surprising that the parameters of fun-
damental importance for assessing meaningful
dose-response relationships also vary for the dif-
ferent types of effects. Stochastic effects, e.g., car-
cinogenesis, need to be evaluated somewhat differ-
ently from many other effects of toxic chemical
substances. With carcinogenic effects, the so called
no-threshold approach is often advocated for
dose-response relationships. In such instances,
mathematical extrapolations to low response rates
and low doses have been used in connection with
safety evaluations. Similar methods for extrapola-
tion may sometimes be used even for non-
stochastic effects. This paper will discuss funda-
mental aspects of dose-response relationships in
general and also take up some mathematical and
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statistical methods that have been used for the
evaluation of nonstochastic effects, methylmercury
poisoning being used as an example.
Fundamental Aspects of
Dose-Response Relations
Because ofits great importance for safety evalua-
tions oftoxic substances, the problem ofextrapola-
tion ofempirical observations to low doses and low
response rates has received considerable attention
in recent years. Various mathematical models have
been proposed for such evaluation of car-
cinogenesis (1). For stochastic effects, there is no
threshold dose for an individual below which he will
show no symptoms and above which symptoms are
certain to appear. Still, there are interindividual var-
iations in sensitivity, and consequently plots of
dose versus probability of effect are conceivably
different among individuals. The population
dose-response curve is an aggregation ofindividual
plots of dose versus probability of effect. In the
case of carcinogenesis, the dose is often expressed
as the product of time and intensity of exposure.
This is not the case with nonstochastic effects. The
relationship between the in situ concentration ofthe
proximal carcinogen and the occurrence of cancer
February 1978 97has not been much studied. Data on such relation-
ships could be expected to be ofvalue in sorting out
factors influencing dose-response relationships for
cancer, but the scarcity of such data makes any
detailed discussion impossible.
The general philosophy of using critical concen-
trations in critical organs in the evaluation of
dose-response relationships for nonstochastic ef-
fects of toxic metals has been elaborated upon by
the Task Group on Metal Toxicity (2). The ter-
minology used in the following sections of this
paper, dealing with nonstochastic effects ofmetals,
will be synonymous with that of the Task Group.
The classical definition of the term "dose" will be
adopted here, i.e., dose will refer to the amount
given or the amount taken in (e.g., gastrointesti-
nally). The critical concentration in the critical
organ is defined as that concentration in an indi-
vidual which gives rise to a certain effect, i.e., the
critical effect. This implies that the critical concen-
tration may vary among individuals in a population.
Further discussion concerning such interindividual
variation in critical organ concentration (critical
body burden, or threshold body burden) can be
found in the following sections of this paper.
The dose-response relationship is the relation be-
tween dose and the proportion ofan exposed popu-
lation that develops a certain effect (e.g., pares-
thesia). When the dose is defined as the amount
taken in, e.g., orally, the dose-response relation-
ship will depend on the interindividual distribution
of critical organ concentrations as well as on the
interindividual distribution of metabolic parameters
(i.e., the absorption, distribution, and retention).
Ifit is assumed that the metabolic parameters are
the same in all individuals, a certain dose always
gives rise to the same organ concentration. The
cumulative distribution of critical organ concentra-
tions among individuals could then be relabeled into
a cumulative distribution of critical doses, i.e. a
dose-response curve. Some important issues
brought to light by the threshold concept can be
isolated under this assumption. Cumulative
(population-related) dose-response curves resulting
from some cases of distributions of critical organ
concentrations (threshold doses) are studied. Ifthe
critical concentration (threshold dose) is the same
in all individuals, the cumulative distribution takes
asingle step from0% to 100% response at this value
(Fig. la). With a rectangular distribution of critical
concentrations (threshold doses) (Fig. lb) the
dose-response curve consists of a straight line be-
tween aO%o and a 100% value. As afinal example, if
the distribution is-logarithmic-normal (Fig. lc), the
dose-response curve is identical with a cumulative
log-normal distribution. Among these distributions
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FIGURE 1. Nonstochastic effects: Distribution of critical organ
concentrations (threshold dose) are shown in the lower
graphs and the corresponding cumulative (population-
related) dose-response curves are shown in the correspond-
ing graph above: (a) all individuals in the population have the
same critical concentration (dose -5); (b) rectangular dis-
tribution of critical organ concentrations; (c) lognormal dis-
tribution of critical organ concentration (threshold doses).
only those shown in Figures la and lb have defi-
nite "thresholds" in the dose-response curve, i.e.
doses > 0 below which there is no response. Gen-
eral biological experience makes it highly unlikely
that distributions with such sharp cut-off values as
those in Figures la and lb do exist. However, there
may be other types of distributions with zero-
response. Curves of the types seen in Figure lc are
frequently found in animal experiments.
In reality, there is not only interindividual varia-
tion in critical organ concentration but also in
metabolism among various individuals. In princi-
ple, no simple relation between the distribution of
critical organ concentrations and the dose-response
curve then holds. The compounded dose-response
relationship depends in a complex way on the rela-
tionship between dose and concentration in the crit-
ical organ and the relationship between concentra-
tion in the critical organ and response, as exemp-
lified by the model for methylmercury poisoning to
be given below. It is a compounded or total
dose-response curve that can be estimated point-
wise in sampled epidemiological investigations and
which is of importance in setting safety limits for
exposure to the public.
Regardless of whether a dose-response curve is
estimated directly from observations or inferred
from a combination of data on metabolic variation
and concentration/response, it will in practice be
difficult to determine its shape in the low-dose re-
gion. The response rates extrapolated for low doses
are often strongly dependent, even for agiven set of
observation data, on what assumptions are made as
to the underlying mathematical function form (3).
This too, will be shown in the example of methyl-
mercury.
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viduals have no definite critical organ concentra-
tions, but individual curves for dose versus proba-
bility of effect which may differ among individuals
due to varying sensitivity and metabolism. The ag-
gregation up to a population dose-response curve is
an averaging procedure, basically the same as in the
case in which critical organ concentrations do exist.
The resulting curve is now determined by the in-
terindividual variation as well as by the typical
shape of the individual curves. Individual relations
between dose and probability of effect cannot in
principle be observed or estimated but are approx-
imated by dose-response curves found for popula-
tions of inbred strains, in which case genetically
determined variation is largely reduced. In Figure 2
some individual dose versus probability of effect
curves of the "ice-hockey-stick" type are shown
together with the resulting population
dose-response curve.
Dose-response curves for acutely toxic sub-
stances are, as a rule, convex downwards for small
dose levels. The curve may be so close to zero for a
range of small dose levels that these may be con-
sidered virtually safe. The shape of the
% Response(Cumulative)
agregate
dose/ response
curve
Dose
% Probability of symptom for individuals
individual
dose/probability of response
curves -
dose-response curve is difficult to estimate practi-
cally for low levels, but if the portion of the curve
that can be reliably estimated has a steep slope, and
if its continuation downwards intersects the dose
axis for some positive dose level, this can be taken
as an indication that there exist "virtually safe"
levels.
Extrapolation of a
Dose-Response Curve for
Methylmercury
The assumptions made about the metabolism and
toxic effects of methylmercury (MeHg) are as fol-
lows. An ingested amount of MeHg is excreted
from the body with a biological halftime t. For any
profile of daily intakes, the resulting development
ofbody burdens can then in principle be calculated.
In particular, after a long time with an average daily
dose d(mg)ofMeHg, a steady-state body burden of
d (t/ln 2) is gradually reached. The value oft varies
among individuals and consequently so does the
equilibrium body burden, with mean and standard
deviation equal tod/ln 2 times those ofthe half-time
distribution. The critical body burden (leading to,
e.g., paresthesia) also varies, independently of the
half-time variation. The bivariate distribution of
half-time and critical body burden can be plotted
(Fig. 3). The probability of poisoning is the proba-
bility mass below a line with slope d/ln 2. Computa-
tion of that mass for varying d yields the
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FIGURE 3. Derivation of the joint distribution from interin-
dividual variation in half-times and interindividual distribu-
tion ofcritical body burdens. The line represents steady state
body burdens at a certain long term daily intake d combined
with the varying half-times along the x-axis. The mass below
the line is the probability of poisoning at dose d.
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FIGURE 2. Stochastic effects: (bottom) individual dose versus
probability-of-effect curves and (top) corresponding (aggre-
gate) dose-response curve for the population.
99dose-response relationship. A detailed description
of the method has been given by Nordberg and
Strangert (4).
The distributions of t and of critical body burden
were estimated as described below.
b = 124.0 + 14.3
k = 1.40 + 0.30
This corresponds to a median value of 95.4 mg for
the critical body burden. The background was esti-
mated at 7.3%.
Estimation of Interindividual Variation in
Threshold Body Burden for Symptoms
In Table 1 are given data according to Bakir et al.
(5), consisting of sets of observations concerning
the frequency of paresthesia in groups of persons
with varying body burdens of methylmercury. The
most frequently used distribution types to which
these data might fit reasonably well are the log-
normal and Weibull distributions. In addition, the
background frequency ofparesthesia in the popula-
tion must be estimated. (It is evident that it would
be of great value to get more precise data on the
background frequency, which may be easily ob-
tained).
Table 1. Observed relationships between body burden of methyl-
mercury (as derived from blood concentrations) and symptoms of
paresthesia in persons exposed to methylmercury in Iraq.a
Number of persons
Body burden, Number of per- with symptoms
mg sons observed (paresthesia)
4 21 2
25 19 1
55 19 8
105 17 10
168 25 20
202 17 14
243 4 4
aData from Bakir et al. (5).
In both bases, a numerical maximum likelihood
estimation procedure was used, based upon the fact
that in each group of exposed persons, the number
of individuals showing symptoms has a binomial
distribution. The covariance matrix ofthe estimates
was estimated by the negative inverse ofthe matrix
ofsecond derivatives ofthelog-likelihood function.
For alog1O-normal distribution, the mean value ,i
and standard deviation d estimated were
fi = 1.949 ± 0.057
d = 0.345 + 0.070
with the body burden of 1 mg taken as reference
level. This corresponds to a median value of89 mg
for the critical body burden. The background was
simultaneously estimated at 6.3%.
For a Weibull distribution,
F(x) = 1 - exp { -[(x - w)Ib]k}
w was set equal to zero, and the parameters b andk
estimated at
Estimation of Interindividual
Variation in Metabolism
Interindividual variation in biological half-time
has been presented by Al-Shahristani and Shihab
(6). They found a normal distribution ofthe biologi-
cal half-time ofmethylmercury with a mean value of
64 days and with a standard deviation of 15 days
representing 89% of the population, the rest of the
population having 119 days as biological half-time.
Although further data on the half-time would be
desirable, the uncertainty in the interindividual
variation in threshold for symptoms has more influ-
ence on the calculated response rates. However,
the part ofthe population with a very long half-time
is a high-risk group that has great relative impor-
tance at low doses. Their proportion is critical to
the calculated values.
Compounded Dose-Response Curves,
Taking into Consideration Interindividual
Variation in Metabolism and in Thresholds
The dose-response curves resulting from compu-
tations taking into consideration both the interin-
dividual variation in threshold body burdens for
symptoms and interindividual variation in biological
half-time for methylmercury are given in Figure 4.
It is evident that the choice of type of distribution
has great influence upon point estimates of re-
sponse for low doses. However, as demonstrated
by the confidence intervals at lower doses, such
Probability
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FIGURE 4. Dose-response curves (point estimates of risk) for
methylmercury poisoning.(--) log-normal model; (-)
Weibull model.
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100estimates do not exclude relatively high (or low)
response rates. For a daily intake of 0.1 mg (in a
50-kg individual) the 90% confidence interval ex-
tends with a factor of approximately 3 above and
below the point estimate of 2.98% (above back-
ground) with the Weibull distribution (Fig. 5a). The
point estimate with the log-normal distribution is
0.40%o. The difference in point estimates by a factor
of more than 7 seems large, but the confidence in-
tervals overlap. There is therefore no clear con-
tradiction between the two mathematical expres-
sions at the dose level 0.1 mg/day. With lower
dose levels such as 0.02 mg/day, the extrapola-
tion results from the two mathematical models can
no longer be reconciled. The point estimate for the
Weibull distribution is 0.32%; with the log-normal
0.00%, the confidence intervals do not overlap (Fig.
5b). Although the (above background) response es-
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FIGURE 5. Probabilities that given risk values exceed the true
value (a) at MeHg dose 0.1 mg/day and (b) at dose 0.02
mg/day: (--) log-normal model: ( ) Weibull model. Bars
indicate 90% confidence intervals.
timates from the two mathematical models differ
from each other, it is evident (with the present set of
data) that the uncertainty in the background esti-
mate overrules the practical importance ofany such
difference. It is usually relatively simple to obtain
more reliable measurements of background fre-
quency and the discussion about the difference be-
tween the mathematical models therefore may be of
practical importance at considerably lower re-
sponse values than those merging into the uncertain
background estimate of the present set of data.
Comments and Discussion
Difficulties involved in the extrapolation of re-
sponses to low doses have been discussed in many
papers. Some general approaches have been pro-
posed for such extrapolation when no mathematical
function type can be pointed out as the valid de-
scription ofthe dose-response relation. Mantel and
Bryan (7) recommend a log-normal functional form
with a conservative standard deviation estimate of
one logarithm (to the base 10) per probit, which is
on the safe side for most acutely toxic substances
(not carcinogens). The value estimated for the pres-
ent model was 0.345 instead of 1.0.
Another approach is advised by Hoel et al. (1),
i.e., linear extrapolation toward zero, assuming no
threshold. The risk obtained this way may be com-
pared to the values obtained with the Weibull
model. The exponent k was estimated in the present
studies to be as low as 1.40, while 1.0 would give an
approximately linear portion near zero doses.
Most papers dealing with extrapolation to low
doses have studied only compounded dose-
response curves. Only in afew instances has it been
possible to sort out various factors, e.g., the influ-
ence of the variation in metabolism, contributing to
the dose-response relationship. It seems that it
would be a useful approach to try to gain more
knowledge about the fundamental factors that to-
gether determine dose-response relationships and
to study the influence of each such factor per se.
In this way a better understanding of the
dose-response relationship will be gained and ulti-
mately lead to a more valid and certain possibility of
extrapolating to low response levels. Such studies
will also give indications concerning upon what
matters to devote further research. In the present
case, for example, it is evident that a further defini-
tion of the interindividual variation in biological
half-time will not add substantially to the final
evaluation, whereas data on the proportion with the
high half-time as well as more data on the factors
influencing the interindividual variation in threshold
will be of great value.
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